BIOMAT Database Logo BIOMAT Database Logo

[Compensated cirrhosis, decompensated cirrhosis]. 1995

K Satomura, and H Komeichi, and T Aramaki
First Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006403 Hematologic Tests Tests used in the analysis of the hemic system. Blood Tests,Hematologic Test,Hematological Tests,Test, Hematologic,Tests, Hematologic,Blood Test,Hematological Test,Test, Blood,Test, Hematological,Tests, Blood,Tests, Hematological
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Satomura, and H Komeichi, and T Aramaki
Survival and prognostic indicators in compensated and decompensated cirrhosis.
May 1986, Digestive diseases and sciences,
K Satomura, and H Komeichi, and T Aramaki
Targeted quantitative lipidomic uncovers lipid biomarkers for predicting the presence of compensated cirrhosis and discriminating decompensated cirrhosis from compensated cirrhosis.
February 2024, Clinical chemistry and laboratory medicine,
K Satomura, and H Komeichi, and T Aramaki
Alteration of micronutrient status in compensated and decompensated liver cirrhosis.
April 2014, Indian journal of clinical biochemistry : IJCB,
K Satomura, and H Komeichi, and T Aramaki
Hexobarbital disposition in compensated and decompensated cirrhosis of the liver.
May 1978, Clinical pharmacology and therapeutics,
K Satomura, and H Komeichi, and T Aramaki
Gastric acid secretion in compensated and decompensated cirrhosis of liver.
October 1983, Indian journal of medical sciences,
K Satomura, and H Komeichi, and T Aramaki
Subclinical ascites defines an intermediate stage between compensated and decompensated cirrhosis.
September 2012, Zeitschrift fur Gastroenterologie,
K Satomura, and H Komeichi, and T Aramaki
Abnormal hemorheological properties in patients with compensated and decompensated hepatic cirrhosis.
January 2003, Clinical hemorheology and microcirculation,
K Satomura, and H Komeichi, and T Aramaki
Clinical outcomes of compensated and decompensated cirrhosis: A long term study.
July 2014, World journal of hepatology,
K Satomura, and H Komeichi, and T Aramaki
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
October 2012, Liver international : official journal of the International Association for the Study of the Liver,
K Satomura, and H Komeichi, and T Aramaki
¹H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis.
January 2012, World journal of gastroenterology,
Copied contents to your clipboard!